Serotonin receptor gene (5-HT1A) modulates alexithymic characteristics and attachment orientation

被引:21
|
作者
Gong, Pingyuan [1 ,2 ,3 ]
Liu, Jinting [1 ,2 ]
Li, She [3 ]
Zhou, Xiaolin [1 ,2 ,4 ,5 ]
机构
[1] Peking Univ, Ctr Brain & Cognit Sci, Beijing 100871, Peoples R China
[2] Peking Univ, Dept Psychol, Beijing 100871, Peoples R China
[3] Henan Univ Sci & Technol, Lab Med Mol Biol, Luoyang 471003, Peoples R China
[4] Peking Univ, Key Lab Machine Percept, Minist Educ, Beijing 100871, Peoples R China
[5] Peking Univ, PKU IDG McGovem Inst Brain Res, Beijing 100871, Peoples R China
基金
中国博士后科学基金;
关键词
Alexithymia; Attachment; Serotonin; Genetic polymorphism; 5-HT1A; ADULT ATTACHMENT; TRANSPORTER GENE; PROMOTER POLYMORPHISM; MAJOR DEPRESSION; STYLE; 5-HTTLPR; SUSCEPTIBILITY; REPRESSION; DISORDERS; BINDING;
D O I
10.1016/j.psyneuen.2014.09.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Previous studies have indicated that alexithymia is associated with the availability of serotonin in the brain and with the insecure attachment orientation. Inspired by the finding that the receptor 5-HT1A modulates the level of serotonin in the brain, this study investigated to what extent a polymorphism (C-1019G, rs6295) of 5-HT1A gene modulates individuals' alexithymic characteristics and attachment orientation in 504 Chinese Han people. Results showed significantly higher total scores on the 20-item Toronto Alexithymia Scale (TAS-20) for individuals carrying the CG/GG genotype than for individuals carrying the CC genotype. Specifically, individuals with the CG/GG genotype reported greater difficulty in identifying own feelings than individuals with the CC genotype. Results also showed that individuals carrying the CG/GG genotype seemed to be less comfortable with having close relationships to others than individuals with the CC genotype. These findings provide the first evidence for the link between 5-HT1A and the development of alexithymic characteristics and attachment orientation. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:274 / 279
页数:6
相关论文
共 50 条
  • [1] STRUCTURE AND FUNCTION OF THE TRANSCRIPTIONAL CONTROL REGION OF THE SEROTONIN 5-HT1A RECEPTOR GENE
    PARKS, CL
    SHENK, T
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 264 - 264
  • [2] Systematic Screening of the Serotonin Receptor 1A (5-HT1A) Gene in Chronic Tinnitus
    Kleinjung T
    Langguth B
    Fischer B
    Hajak G
    Eichhammer P
    Sand PG
    JournalofOtology, 2006, (02) : 83 - 85
  • [3] New serotonin 5-HT1a receptor antagonists.
    Oya, S
    Kung, MP
    Mu, M
    Kung, HF
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 216 : U243 - U243
  • [4] Mechanistic Studies on the Stereoselectivity of the Serotonin 5-HT1A Receptor
    Yuan, Shuguang
    Peng, Qian
    Palczewski, Krzysztof
    Vogel, Horst
    Filipek, Slawomir
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2016, 55 (30) : 8661 - 8665
  • [5] The 5-HT1A receptor modulates the effects of cocaine on extracellular serotonin and dopamine levels in the nucleus accumbens
    Andrews, CM
    Kung, HF
    Lucki, I
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2005, 508 (1-3) : 123 - 130
  • [6] SEROTONIN-INDUCED 5-HT1A RECEPTOR DESENSITIZATION IN C6BU-1 GLIOMA-CELLS TRANSFECTED WITH 5-HT1A RECEPTOR GENE
    SAITOH, K
    MIKUNI, M
    IKEDA, M
    YAMAZAKI, C
    TOMITA, U
    TAKAHASHI, K
    NEUROSCIENCE LETTERS, 1995, 199 (03) : 191 - 194
  • [7] Novel Selective Arylpiperazine Ligands for the Serotonin 5-HT1a Receptor
    Romeo, G.
    JOINT MEETING ON MEDICAL CHEMISTRY, 2009, : 15 - 19
  • [8] Identification of serotonin 5-HT1A receptor partial agonists in ginger
    Nievergelt, Andreas
    Huonker, Peter
    Schoop, Roland
    Altmann, Karl-Heinz
    Gertsch, Juerg
    BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (09) : 3345 - 3351
  • [9] The Serotonin 1A (5-HT1A) Receptor as a Pharmacological Target in Depression
    Smith, Alexander L. W.
    Harmer, Catherine J.
    Cowen, Philip J.
    Murphy, Susannah E.
    CNS DRUGS, 2023, 37 (7) : 571 - 585
  • [10] The Serotonin 1A (5-HT1A) Receptor as a Pharmacological Target in Depression
    Alexander L. W. Smith
    Catherine J. Harmer
    Philip J. Cowen
    Susannah E. Murphy
    CNS Drugs, 2023, 37 : 571 - 585